2Johannesson M, Dahlof B, Lindholm LH, et al. The cost-effectiveness of treating hypertension in elderly people-an analysis of the Swedish Trial in Old Patients with Hypertension(STOP Hypertension)[J]. J Intern Med, 1993, 234(3) :317-323.
3J Wikstrand Primary prevention in patients with hypertension: comments on the clinical implications of the MAPHY Study. Metoprolol Atherosclerosis Prevention in Hypertensives Study[J]. Am Heart J,1988,116(1 Pt 2) :338-347.
4UK Prospective Diabetes Study Group (UKDPS). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ, 1998, 317(7160) :703-713.
5Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiot ensin-conver ting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial[J]. Lancet, 1999,353(9153) : 611-616.
6Hasson L, Lindholm H, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity [J]. Lancet, 1999,354 (9192): 1751-1756.
7Staessen JA, Wang J G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta analysis[J]. Lancet, 2001,358 (9290): 1305-1315.
8叶任高,陆再英.内科学[M].6版.北京:人民卫生出版社,2004:254-255.
9Packer M,Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure [J]. N Engl J Med, 2001,344(22) : 1651-1658.
10Segev A, Mekori YA. The Cardiac Insufficiency Bisoprolol Study Ⅱ (CIBIS-Ⅱ)[J]. Lancet, 1999,353(9161) : 1361.
